Recro Pharma Inc. (REPH)
NASDAQ: REPH
· Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM
Recro Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 8.1M | 8.16M | 6.29M | 14.99M | 11.58M | 15.48M | 15.28M | 25.22M | 23.49M | 45.72M | 11.56M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.9M | 2M | 2.05M | 7.49M | 2.93M | 246K | 246K | 246K | 146K | 451K | 470K |
Receivables | 16.58M | 14.77M | 15.23M | 15.95M | 17.1M | 16.52M | 14.12M | 11.91M | 13.75M | 12.81M | 12.43M |
Inventory | 10.26M | 12.28M | 11.57M | 10.3M | 9.41M | 8.37M | 9.47M | 8.92M | 9.44M | 7.88M | 8.64M |
Other Current Assets | 18.53M | 14.58M | 14.74M | 14.34M | 11.4M | 11.6M | 10.82M | 11.48M | 9.41M | 9.38M | 9.32M |
Total Current Assets | 53.46M | 49.78M | 47.84M | 55.59M | 49.49M | 51.98M | 49.69M | 57.53M | 56.09M | 75.79M | 41.94M |
Property-Plant & Equipment | 54.8M | 56.26M | 56.23M | 50.37M | 54.63M | 56.67M | 57.17M | 57.63M | 55.98M | 41.87M | 42.77M |
Goodwill & Intangibles | 43.32M | 43.48M | 43.82M | 44.01M | 44.23M | 44.47M | 44.69M | 44.91M | 45.56M | 4.32M | 4.37M |
Total Long-Term Assets | 100.01M | 101.75M | 102.1M | 101.86M | 101.78M | 101.38M | 102.11M | 102.79M | 101.69M | 46.64M | 47.61M |
Total Assets | 153.47M | 151.53M | 149.94M | 157.44M | 151.28M | 153.36M | 151.8M | 160.32M | 157.78M | 122.43M | 89.55M |
Account Payables | 1.31M | 2.12M | 2.39M | 1.47M | 3.06M | 2.34M | 1.56M | 2.08M | 1.92M | 1.16M | 1.54M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1.84M | 2.31M | 2.32M | 1.07M | 1.4M |
Short-Term Debt | 37.86M | 10.99M | 8.93M | 8.66M | 3.11M | 3.11M | 3.1M | 3.09M | 3.09M | n/a | 2.58M |
Other Current Liabilities | 10.81M | 8.51M | 8.21M | 12.69M | 8.01M | 7.78M | 6.34M | 12.56M | 7.86M | 4.15M | 3.99M |
Total Current Liabilities | 49.99M | 21.62M | 19.53M | 22.81M | 14.18M | 13.23M | 11M | 17.73M | 12.86M | 5.3M | 8.11M |
Long-Term Debt | 4.15M | 4.27M | 4.48M | 4.58M | 4.68M | 4.77M | 4.85M | 4.93M | 4.95M | n/a | n/a |
Other Long-Term Liabilities | 40.67M | 67.38M | 69.95M | 70.19M | 97.19M | 98.03M | 96.79M | 95.59M | 95.49M | 90.71M | 90.17M |
Total Long-Term Liabilities | 44.82M | 71.65M | 74.43M | 74.78M | 101.86M | 102.8M | 101.64M | 100.52M | 100.44M | 90.71M | 90.17M |
Total Liabilities | 94.81M | 93.27M | 93.96M | 97.58M | 116.05M | 116.03M | 112.64M | 118.25M | 113.3M | 96.01M | 98.28M |
Total Debt | 42.01M | 15.26M | 13.41M | 13.24M | 7.79M | 7.88M | 104.67M | 103.52M | 102.32M | 89.78M | 91.48M |
Common Stock | 1.05M | 1.05M | 849K | 846K | 567K | 566K | 565K | 467K | 466K | 465K | 310K |
Retained Earnings | -278.91M | -278.12M | -270.32M | -265.63M | -256.47M | -253.14M | -250.02M | -245.75M | -243.4M | -239.91M | -241.15M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.52M |
Shareholders Equity | 58.66M | 58.26M | 55.98M | 59.86M | 35.23M | 37.33M | 39.16M | 42.06M | 44.48M | 26.42M | -8.72M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |